LXRX Q1 2017 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

LXRXLexicon Pharmaceuticals, Inc.

$693M

Q1 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$18M+46.4% YoY

Gross Profit

$18M98.8% margin

Operating Income

-$42M-232.2% margin

Net Income

-$35M-190.7% margin

EPS (Diluted)

$-0.33

QoQ Revenue Growth

-20.6%

Cash Flow

Operating Cash Flow

-$85M

Free Cash Flow

-$86M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$396M

Total Liabilities

$262M

Stockholders' Equity

$135M

Cash & Equivalents

$260M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$18M	$12M	+46.4%
Gross Profit	$18M	-$25M	+173.7%
Operating Income	-$42M	-$34M	-25.4%
Net Income	-$35M	-$35M	-0.0%